ISO/TC 194
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 84512 | ISO/FDIS 10993-1 | Biological evaluation of medical devices — Part 1: Requirements and general principles for the evaluation of biological safety within a risk management process | Izstrādē |
| 86248 | ISO/PWI TS 10993-22 | Biological evaluation of medical devices — Part 22: Guidance on nanomaterials | Izstrādē |
| 86246 | ISO/FDIS 10993-2 | Biological evaluation of medical devices — Part 2: Animal welfare requirements | Izstrādē |
| 85211 | ISO/PWI 10993-5 | Biological evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity | Izstrādē |
| 39204 | ISO 10993-12:2002/DAmd 1 | Biological evaluation of medical devices — Part 12: Sample preparation and reference materials — Amendment 1 | Izstrādē |
| 91724 | ISO/NP TS 25364-4 | Analytical chemistry matters associated with ISO 10993-18 — Part 4: Critical aspects of extract viability in extractables and leachables testing using non-targeted analysis (NTA) | Izstrādē |
| 86247 | ISO/AWI TS 20324 | Generation of medical device extracts for chemical analysis to support toxicological risk assessment | Izstrādē |
| 64751 | ISO/NP TS 10993-19 | Biological evaluation of medical devices — Part 19: Physico-chemical, morphological and topographical characterization of materials | Izstrādē |
| 45368 | ISO/CD 10993-3 | Biological evaluation of medical devices — Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity | Izstrādē |
| 41176 | ISO/PWI 14155-1 | Clinical investigation of medical devices for human subjects — Part 1: General requirements | Izstrādē |
Displaying 21-30 of 146 results.